Today's Clinical Lab - News, Editorial and Products for the Clinical Laboratory

White Paper

Break the Cycle of Untreated Syphilis with Rapid Testing

Transform care in high-incidence settings with a 10-minute test that delivers same-visit treatment and better outcomes

Syphilis cases are at a 70-year high in the U.S., with many infections going undiagnosed due to delays in testing. Traditional lab-based tests can take days or weeks to return results, leaving patients untreated and increasing community transmission.

Social image


The Diagnostics Direct Syphilis Health Check™ test provides results in just 10 minutes, allowing clinicians to diagnose and treat patients during the same visit. This rapid treponemal test detects IgM antibodies, offering 96 percent sensitivity for primary syphilis—ensuring early and reliable detection. Its simple fingerstick design makes it ideal for challenging settings, including rural clinics and outreach programs.

Dr. Jeffrey Klausner, professor of medicine and public health at the University of Southern California, is a leading expert on STI prevention with over 25 years of research funded by the CDC and NIH. His research into rapid testing and the test-and-treat model emphasizes its potential to address care gaps nationwide and curb the growing syphilis epidemic.


Access the white paper and discover:

  • Why Dr. Klausner champions rapid diagnostics to transform clinical workflows

  • Exclusive performance data comparing sensitivity and specificity across testing methods

  • How two drops of blood can test for both syphilis and HIV, streamlining care for high-risk populations

  • What makes same-visit testing a powerful solution for reducing follow-up challenges and ensuring timely treatment


Sponsored by